Absolute bioavailability and metabolic disposition of valaciclovir, the L-valyl ester of acyclovir, following oral administration to humans.

Samankaltaisia teoksia

• Lack of interaction between valaciclovir, the L-valyl ester of aciclovir, and digoxin
  Tekijä: Soul-Lawton, J H, et al.
  Julkaistu: (1998)
• Phase I trial of valaciclovir, the L-valyl ester of acyclovir, in patients with advanced human immunodeficiency virus disease.
  Tekijä: Jacobson, M A, et al.
  Julkaistu: (1994)
• The absolute bioavailability and metabolic disposition of the novel antimigraine compound zolmitriptan (311C90)
  Tekijä: Seaber, E., et al.
  Julkaistu: (1997)
• Multiple Interactions of Cimetidine and Probenecid with Valaciclovir and Its Metabolite Acyclovir
  Tekijä: De Bony, F., et al.
  Julkaistu: (2002)
• Disposition kinetics of a dipeptide ester prodrug of acyclovir and its metabolites following intravenous and oral administrations in rat
  Tekijä: Talluri, Ravi S., et al.
  Julkaistu: (2009)